大学紹介、カリキュラム、キャンパスライフ、入試情報等、順天堂大学医学部に関する様々な情報をご案内します。

受験生の皆様へ在学生の皆様へ卒業生の皆様へ一般の皆様へ医療関係の皆様へ
講座・研究室
医学部紹介入学案内教育カリキュラムキャンパスライフ講座・研究室交通アクセスお問い合わせ
講座・研究室

臨床検査医学講座　【業績】

｜トップページ｜臨床検査医学講座紹介｜スタッフ紹介｜順天堂医院診療科｜大学院医学研究科｜English｜
｜英文業績｜
：2011年　2010年　2009年　2008年　2007年　2006年　2005年　2004年　2003年　2002年　2001年　
｜和文業績｜
：原著（ 2009年　2008年　2007年　2006年　2005年　2004年　2003年　2002年　2001年 ）
：著書（ 2009年　2008年　2007年　2006年　2005年　2004年　2003年　2002年　2001年 ）
：総説・その他報告 ：症例報告（ 2004年 )

■英文論文

　2011年
  1. Nagasaka H, Yorifuji T, Takatani T, Okano Y, Tsukahara H, Yanai H, Hirano KI, Hui SP, Hirayama S, Ito T, Chiba H, Miida T. CD36 deficiency predisposing young children to hypoglycemia. Metabolism (in press)
  2. Tabe Y, Kawase Y, Miyake K, Satoh N, Aritaka N, Isobe Y, Oshimi K, Komatsu N, Miida T, Ohsaka A. Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis. Clin Chem Lab Med (in press)
  3. Jin L, Tabe Y, Kimura S, Zhou Y, Kuroda J, Asou H, Inaba T, Konopleva M, Andreeff M, Miida T. Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma. Br J Cancer, Vol. 104, No. 1, 91-100, 2011.
  4. Sanayama Y, Nagasaka H, Takayanagi M, Ohura T, Sakamoto O, Ito T, Ishige-Wada M, Usui H, Yoshino M, Ohtake A, Yorifuji T, Tsukahara H, Hirayama S, Miida T, Fukui M, Okano Y. Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Mol Genet Metab (in press)
  5. Horiuchi Y, Tabe Y, Idei M, Bengtsson HI, Ishii K, Horii T, Miyake K, Satoh N, Miida T, Ohsaka A. The use of CellaVision Competency Software for external quality assessment and continuing professional development. J Clin Pathol (in press)
  6. Fukushima Y, Hirayama S, Ueno T, Dohi T, Miyazaki T, Ohmura H, Mokuno H, Miyauchi K, Miida T, Daida H. Small dense LDL cholesterol is a robust therapeutic marker of statin treatment in patients with acute coronary syndrome and metabolic syndrome. Clin Chim Acta (in press)
  7. Nagasaka H, Tsukahara H, Takatani T, Sanayama Y, Takayanagi M, Ohura T, Sakamoto O, Ito T, Wada M, Yoshino M, Ohtake A, Yorifuji T, Hirayama S, Miida T, Fujimoto H, Mochizuki H, Hattori T, Okano Y. Cross-sectional study of bone metabolism with nutrition in adult classical phenylketonuric patients diagnosed by neonatal screening. J Bone Miner Metab (in press)
　2010年
  1. Miida T, Hirayama S. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Curr Opin Lipidol, Vol. 21, No. 1, 70-75, 2010.
  2. Nagasaka H, Okano Y, Aizawa M, Miida T, Yorifuji T, Tajima, G Sakura N, Takatani T, Sanayama Y, Sugamoto K, Mayumi M, Kobayashi K, Hirano K, Takayanagi M, Tsukahara H. Altered metabolisms of mediators controlling vascular function and enhanced oxidative stress in asymptomatic children with congenital portosystemic venous shunt. Metabolism, Vol. 59, No. 1, 107-113, 2010.
  3. Hirayama S, Soda S, Ito Y, Matsui H, Ueno T, Fukushima Y, Ohmura H, Hanyu O, Aizawa Y, Miida T. Circadian change of serum concentration of small dense LDL-cholesterol in type 2 diabetic patients. Clin Chim Acta, Vol. 411, No. 3-4, 253-257, 2010.
  4. Kojima K, Konopleva M, Tsao T, Andreeff M, Ishida H, Shiotsu Y, Jin L, Tabe Y, Nakakuma H: Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis. Leukemia, Vol. 24, No. 1, 33-43, 2010.
  5. Horiuchi Y, Hirayama S, Seino U, Kon K, Ueno T, Ohmura H, Hanyu O, Tsuda T, Miida T. Statin therapy reduces inflammatory markers in hypercholesterolemic patients who have high baseline levels. J Atheroscler Thromb, Vol. 17, No. 7, 722-729, 2010.
  6. Nagasaka H, Yorifuji T, Kobayashi K, Takikawa H, Komatsu H, Inui A, Fujisawa T, Miida T, Tsukahara H, Takatani T, Hayashi H. Favorable effect of 4-phenylacetate on liver functions attributable to enhanced bile salt export pump expression in ornithine transcarbamylase-deficient children. Molecular Genetics and Metabolism, Vol. 100, No. 2, 123-128, 2010.
  7. Miida T, Hirayama S. Preβ1‐HDL: A native lipid-poor HDL, and its potential as a new marker for HDL metabolism (Chapter 12). In: The HDL Handbook ‐ Biological Functions and Clinical Implications -. (Komoda T, Ed), Academic Press, London (UK), Burlington, San Diego (U.S.A.), p243-259, 2010.
  8. Kon M, Hirayama S, Horiuchi Y, Ueno T, Idei M, Fueki Y, Seino U, Goto S, Maruyama H, Iino H, Fukushima Y, Ohmura H, Hirowatari Y, Miida T. Profiles of inflammatory markers and lipoprotein subclasses in patients undergoing continuous ambulatory peritoneal dialysis. Clin Chim Acta, Vol. 411, No. 21-22, 1723-1727, 2010.
  9. Hiki　M, Shimada K, Kiyanagi T, Fukao K, Hirose K, Ohsaka H, Fukushima Y, Kume A, Matsumori R, Sumiyoshi K, Miyazaki T, Ohmura H, Kurata T, Miida T, Daida H. Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease. Circ J, Vol. 74, No. 7, 1471-1478, 2010.
  10. Ikeuchi T, Hirayama S, Miida T, Fukamachi I, Tokutake T, Ebinuma H, Takubo K, Kaneko H, Kasuga K, Kakita A, Takahashi H, Bujo H, Saito Y, Nishizawa M. Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease. Dement Geriatr Cogn Disord, Vol. 30, No. 1, 28-32, 2010.
  11. Jin L, Tabe Y, Kojima K, Zhou Y, Pittaluga S, Konopleva M, Miida T, Raffeld M. MDM2 antagonist Nutlin-3 enhances bortezomib-mediated mitochondrial apoptosis in TP53-mutated mantle cell lymphoma. Cancer Lett, Vol. 299, No. 2, 161-170, 2010.
  12. Tomomatsu J, Isobe Y, Oshimi K, Tabe Y, Ishii K, Noguchi M, Hirano T, Komatsu N, Sugimoto K. Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutated IGH gene, and indolent clinical behavior. Leuk Lymphoma, Vol. 51, No. 12, 2230-2239, 2010.
  13. Kimura S, Mitsuma W, Ito M, Suzuki H, Hosaka Y, Hirayama S, Hanyu O, Hirono S, Kodama M, Aizawa Y. Inverted Takotsubo contractile pattern caused by pheochromocytoma with tall upright T-waves, but not typical deep T-wave inversion. Int J Cardiol, Vol. 139, No. 2, e15-17. 2010.
　2009年
  1. Yamato S, Shinohara K, Nakagawa S, Kubota A, Inamura K, Watanabe G, Hirayama S, Miida T, Ohta S: HPLC determination of ketone bodies in human plasma by precolumn derivatization with p-nitrobenzene diazonium fluoroborate ketone body. Analytical Biochemistry, Vol. 384, No. 1: 145-150, 2009.
  2. Hirayama S, Ito T, Miyazaki O, Kamimura T, Hanyu O, Seino U, Ito S, Aizawa Y, Miida T: Preβ1-HDL is elevated in the fasting state, but markedly reduced postprandially in poorly controlled type 2 diabetic patients. Clin Chim Acta, Vol. 401, No. 1-2: 57-62, 2009.
  3. Tabe Y, Sebasigari D, Jin L, Rudelius M, Davies-Hill T, Miyake K, Miida T, Pittaluga S, Raffeld M: The MDM2 antagonist Nutlin-3 displays anti-proliferative and pro-apoptotic activity in mantle cell lymphoma. Clin.Cancer Res, Vol. 15, No. 3, 933-942, 2009.
  4. Matsumoto S, Ogawa H, Soda S, Hirayama S, Amarasena N, Aizawa Y, Yoshihara A, Miyazaki H: Effect of antimicrobial periodontal treatment and maintenance on serum adiponectin in Type 2 diabetes mellitus. J Clin Periodontol, Vol. 36, No. 2: 142-148, 2009.
  5. Kimura S, Mitsuma W, Ito M, Suzuki H, Hosaka Y, Hirayama S, Hanyu O, Hirono S, Kodama M, Aizawa Y: Inverted Takotsubo contractile pattern caused by pheochromocytoma with tall upright T-waves, but not typical deep T-wave inversion. Int J Cardiol.　(in press）
  6. Nagasaka H, Yorifuji T, Hirano K, Ota A, Toyama-Nakagawa Y, Takatani T, Tsukahara H, Kobayashi K, Takayanagi M, Inomata Y, Uemoto S, Miida T: Effects of bezafibrate on dyslipidemia along with cholestasis in children with FIC1 deficiency manifesting progressive familial intrahepatic cholestasis. Metabolism, Vol. 58, No. 1: 48-54, 2009.
  7. Nagasaka H, Tsukahara H, Yorifuji T, Miida T, Murayama K, Tsuruoka T, Takatani T, Kanazawa M, Kobayashi K, Okano Y, Takayanagi M: Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects. Metabolism, Vol. 58, No. 3: 278-282, 2009.
  8. Nagasaka H, Okano Y, Tsukahara H, Shigematsu Y, Momoi T, Yorifuji J, Miida T, Ohura T, Kobayashi K, Saheki T, Hirano K, Takayanagi M, Yorifuji T: Sustaining hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in Japanese children with aspartate/glutamate carrier isoform 2-citrin- deficiency even during the silent period. Mol Genet Metab, Vol. 97, No. 1: 21-26, 2009.
  9. Sogo T, Nagasaka H, Komatsu H, Inui A, Miida T, Callea F, Flancalanci P, Hirano K, Kitamura H, Yorifuji T, Fujisawa T: A young Japanese boy with fibrinogen storage disease caused by Aguadilla mutation presenting with hypobeta-lipoproteinemia together with considerable liver disease. J Pediatr Gastroenterol Nutr, Vol. 49, No. 1: 133-136, 2009.
  10. Naito T, Mizue S, Misawa S, Nakamura A, Isonuma H, Kondo S, Dambara T, Yamamoto N: Cyclospora infection in an immunocompetent patient in Japan. Jpn J Infect Dis, Vol. 62, No. 1, 57-58, 2009.
  11. Hanyu O, Yoshida J, Abe E, Hirayama S, Miyake K, Aizawa Y, Miida T: High sensitive CRP and SAA reflect insulin resistance in smokers. J Atheroscler Thromb. Vol. 16, No. 5, 560-567, 2009.
  12. Miyake K, Miyake N, Kondo S, Tabe Y, Ohsaka A, Miida T: Seasonal variation in liver function tests: A time-series analysis of outpatient data. Ann Clin Biochem, Vol. 46, No. 5: 377-384, 2009.
  13. Nagasaka H, Yorifuji T, Momoi T, Yorifuji J, Hirano K, Ota A, Takatani T, Tsukahara H, Takayanagi M, Kobayashi K, Chiba H, Sato Y, Miida T: Lipoprotein profile in children with two common cholesteryl ester transfer protein gene mutations, D442G and I14A, during the first year of life. Clin Chim Acta, Vol. 406, No. 1-2: 52-56, 2009.
  14. Konopleva M, Tabe Y, Zeng Z, Andreeff M: Therapeutic targeting of microenvironmental interactions in leukemia: Mechanisms and approaches. Drug Resist Updat. Vol. 12, No. 4-5, 103-113, 2009.
▲上へ
　2008年
  1. Miida T, Seino U, Miyazaki O, Hanyu O, Hirayama S, Saito T, Ishikawa Y, Akamatsu S, Nakano T, Nakajima K, Okazaki M, Okada M.　Probucol markedly reduces HDL phospholipids and elevated preβ1-HDL without delayed conversion into α-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling. Atherosclerosis, Vol. 200, No. 2, 329-335, 2008.
  2. Wardaningsih E, Miida T, Seino U, Fueki Y, Ito M, Nagasaki K, Kikuchi T, Uchiyama M, Hirayama S, Hanyu O, Miyake K, Okada M. Low adiponectin state is associated with metabolic abnormalities in obese children, particularly depending on apolipoprotein E phenotype. Ann Clin Biochem, Vol. 45, No. 5, 496-503, 2008.
  3. Hirowatari Y, Yoshida H, Fueki Y, Ito M, Ogura Y, Sakurai N, Miida T. Measurement of cholesterol levels of major serum lipoprotein classes in hemodialysis patients by anion-exchange chromatography. Ann Clin Biochem, Vol. 45, No. 6, 571-574, 2008.
  4. Xu Y, Tabe Y, Jin L, Watt J, McQueen T, Ohsaka A, Andreeff M, Konopleva M. TGF-β receptor kinase inhibitor LY2109761 reverses the anti-apoptotic effects of TGF-β1 in myelo-monocytic leukemic cells co-cultured with stromal cells. British J Haematol, Vol. 142, No. 2, 192-201, 2008.
  5. Nagasaka H, Miida T, Hirano K, Ota A, Maruyama K, Yorifugi T, Kobayashi K, Takatani T, Tsukahara H, Hui SP, Takayanagi M, Chiba H. Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome. Atherosclerosis, Vol. 198, No. 2, 434-440, 2008.
  6. Nagasaka H, Miida T, Hirano K, Ota A, Yorifuji T, Takatani T, Tsukahara H, Takayanagi M, Hui SP, Kobayashi K, Chiba H. Reduced apolipoprotein E-rich high-density lipoprotein (HDL) level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life. J Clin Endocrinol Metab, Vol. 93, No. 3, 779-783, 2008.
  7. Jin L, Tabe Y, Konoplev S, Xu Y, Leysath CE, Lu H, Kimura S, Ohsaka A, Rios MB, Calvert L, Kantarjian H, Andreeff M, Konopleva M. CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Mol Cancer Ther, Vol. 7, No. 1, 48-58, 2008.
  8. Obayashi K, Olsson M, Anan I, Ueda M, Nakamura M, Okamoto S, Yamashita T, Miida T, Ando Y, Suhr OB. Impact of serotonin transporter and catechol-O-methyl transferase genes polymorphism on gastrointestinal dysfunction in Swedish and Japanese familial amyloidotic polyneuropathy patients. Clin Chim Acta, Vol. 398 No. 1-2, 10-14, 2008.
  9. Ota T, Kitano T, Miyai K, Ogishima D, Yoshida M, Miyake K ,Kinoshita K. Small cell carcinoma of the uterine cervix metastasizing to the bone marrow: A case report. J.Obstet. Gynaecol. Res, Vol.34, No.4 Part II, 692-695, 2008.
▲上へ
　2007年
  1. Miida T, Takahashi A, Ikeuchi T. Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects. Pharmacology & Therapeutics, Vol. 113, No. 2, 378-393, 2007.
  2. Nagasaka H, Hirano K, Ohtake A, Miida T, Takatani T, Murayama K, Yorifuji T, Kobayashi K, Kanazawa M, Ogawa A, Takayanagi M. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk. European Journal of Pediatrics, Vol. 166, No. 10, 1009-1016, 2007.
  3. Nagasaka H, Chiba H, Hui S-P, Takikawa H, Miida T, Takayanagi M, Yorifuji T, Hasegawa M, Ota A, Hirano K, Kikuchi H, Tsukahara H, Kobayashi K. Depletion of high-density lipoprotein and appearance of triglyceride-rich low-density lipoprotein in a Japanese patient with FIC1 deficiency manifesting benign recurrent intrahepatic cholestasis. Journal of Pediatric Gastroenterology and Nutrition, Vol. 45, No. 1, 96-105, 2007.
  4. Hirayama S, Miida T, Miyazaki O, Aizawa Y. Preβ1-HDL concentration is a predictor of carotid atherosclerosis in type 2 diabetic patients. Diabetes Care, Vol. 30, No. 5, 1289-1291, 2007.
  5. Fueki Y, Miida T, Wardaningsih E, Ito M, Nakamura A, Takahashi A, Hanyu O, Tsuda A, Saito H, Hama H, Okada M. Regular alcohol consumption improves insulin resistance in healthy Japanese men independent of obesity. Clin Chim Acta, Vol. 382, No. 1-2, 71-76, 2007.
  6. Sato H, Miida T, Wada Y, Mruyama M, Murakami S, Hasegawa H, Kuroda T, Narita I, Gejyo F. Atherosclerosis is accelerated in well-controlled Systemic Lupus Erythematosus (SLE) even in the premenopausal state, and further exaggerated in the postmenopausal state. Clin Chim Acta, Vol. 385, No. 1-2, 35-42, 2007.
  7. Ebinuma H, Miida T, Yamauchi T, Hada Y, Hara K, Kubota N, Kadowaki T. Improved ELISA assay for selective measurements of adiponectin multimers, and identification of adiponectin in human cerebrospinal fluid. Clin Chem, Vol. 53, No. 8, 1541-1544, 2007.
  8. Hanyu O, Miida T, Kosuge K, Ito T, Soda S, Hirayama S, Wardaningsih E, Fueki Y, Obayashi K, Aizawa Y. Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents. Clin Chim Acta, Vol. 384, No. 1-2, 118-123, 2007.
  9. Tabe Y, Jin L, Contractor R, Gold D, Ruvolo P, Radke S, Xu Y, Tsutusmi-Ishii Y, Miyake K, Miyake N, Kondo S, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1.Cell Death Differ, Vol 14, No. 8, 1443-1456, 2007.
  10. Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, Priebe W, Mills GB, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.Cancer Res, Vol. 67, No. 2, 684-694, 2007.
  11. Tabe Y, Konopleva M, Kondo Y, Contractor R, Tsao T, Konoplev S, Shi Y, Ling X, Watt JC, Tsutsumi-Ishii Y, Ohsaka A, Nagaoka I, Issa JP, Kogan SC, Andreeff M. PPARgamma-Active Triterpenoid CDDO Enhances ATRA-Induced Differentiation in APL. Cancer Biol Ther, Vol. 6, No. 12, 1967-1977, 2007.
  12. Kuroda J, Kimura S, Strasser A, Andreeff M, O'reilly LA, Ashihara E, Kamitsuji Y, Yokota A, Kawata E, Takeuchi M, Tanaka R, Tabe Y, Taniwaki M, Maekawa T. Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia. Cell Death Differ, Vol. 14, No. 9, 1667-1677, 2007.
  13. Milella M, Konopleva M, Precupanu CM, Tabe Y, Ricciardi MR, Gregorj C, Collins SJ, Carter BZ, D'Angelo C, Petrucci MT, Foa R, Cognetti F, Tafuri A, Andreeff M. MEK blockade converts AML differentiating response to retinoids into extensive apoptosis. Blood, Vol. 109, No. 5, 2121-2129, 2007.
  14. Nakamura A, Oguri T, Misawa S, Tabe Y, Kondo S, Miyake K, Miyake N, Igari J, Ohsaka A. In vitro activity of cefotiam against oxacillin-resistant Staphylococcus epidermidis strains--reevaluation of beta-lactam antibiotics efficiency on MRSE. Jpn J Antibiot, Vol. 60, No. 3, 153-160, 2007.
  15. Ito M, Kodama M, Tsumanuma I, Ramadan MM, Hirayama S, Kamimura T, Kashimura T, Fuse K, Hirono S, Okura Y, Aizawa Y. Relationship between insulin-like growth factor-I and brain natriuretic peptide in patients with acromegaly after surgery. Circ J 71, 1955-7, 2007.
▲上へ
　2006年
  1. Kosuge K, Miida T, Takahashi A, Obayashi K, Ito M, Ito T, Soda S, Ozaki K, Hirayama S, Hanyu O, Aizawa Y, Nakamura Y. Estimating the fasting triglyceride concentration from the postprandial HDLcholesterol and apolipoprotein CIII concentrations. Atherosclerosis, Vol. 184, No. 2, 413-419, 2006.
  2. Miida T, Yamada T, Seino U, Ito M, Fueki Y, Takahashi A, Kosuge K, Soda S, Hanyu O, Obayashi K, Miyazaki O, Okada M. Serum amyloid A (SAA)-induced remodeling of CSF-HDL. Biochim Biophys Acta, Vol 1761, No. 4, 424-433, 2006.
  3. Zhu Y, Yao J, Meng Y, Kasai A, Hiramatsu N, Hayakawa K, Miida T, Takeda M, Okada M, Kitamura M. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system. Br J Pharmacol, Vol. 148, No. 6, 833-844, 2006.
  4. Tabe Y, Konopleva M, Contractor R, Munsell M, Schober WD, Jin L, Tsutsumi-Ishii Y, Nagaoka I, Igari J, Andreeff M. Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells. Blood. Vol. 107, No. 4, 1546-1554, 2006.
  5. Tabe Y, Konopleva M, Kondo Y, Contractor R, Jin L, Ruvolo V, Tsutsumi-Ishii Y, Miyake K, Miyake N, Ohsaka A, Nagaoka I, Issa JP, Andreeff M. PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter. Ann Hematol, Vol. 85, No. 10, 689-704, 2006.
  6. Jiang M, Bujo H, Zhu Y, Yamazaki H, Hirayama S, Kanaki T, Shibasaki M, Takahashi K, Schneider WJ, Saito Y. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells. Biochem Biophys Res Commun, 348, 1367-1377, 2006.
▲上へ
　2005年
  1. Miida T, Takahashi A, Tanabe N, Ikeuchi T. Can statins really reduce the risk of Alzheimer's disease and slow its progression?? Curr Opin Lipidol, Vol. 16, No. 6, 619-623, 2005.
  2. Obayashi K, Hanyu O, Miida T, Ando Y, Nakamura M, Zhu Y, Okada M. Circadian rhythm of protein C in human plasma: Useful marker of autonomic function in liver. Clin Auton Res, Vol. 15, No. 1, 57-58, 2005.
  3. Saga D, Sakatsume M, Ogawa A, Tsubata Y, Kaneko Y, Kuroda T, Sato F, Ajiro J, Kondo D, Miida T, Narita I, Gejyo F. Bezafibrate suppresses rat anti-glomerular basement membrane crescentic glomerulonephritis. Kidney International, Vol. 67, No. 5, 1821-1829, 2005.
  4. Hirayama S, Miida T, Obayashi K, Yamazaki F, Yamazaki-Sakurai M, Ito M, Saito Y, Hanyu O, Suzuki K, Aizawa Y. Effect of apolipoprotein E (apoE) phonotypes on apoE content of CSF-HDL in children. Clin Chim Acta, Vol. 356, No. 1-2, 110-116, 2005.
  5. Zhu Y, Okada M, Matsuto T, Miida T. Prediction of the three-dimensional structure of proteins in the lipid monolayer on the basis of α-helix bundling: Apolipoprotein B-100 structure. Acta Medica et Bologica, Vol. 53, No.2, 51-60, 2005.
▲上へ
　2004年
  1. Miida T, Hirayama S, Nakamura Y. Cholesterol-independent effects of statins and its new therapeutic targets: ischemic stroke and dementia. J Atheroscler Thromb, Vol. 11, No. 5, 253-264, 2004.
  2. Okada M, Matsuto T, Miida T, Obayashi K, Zhu Y, Fueki Y. Lipid analyses for the management of vascular diseases. J Atheroscler Thromb, Vol. 11, No. 4, 190-199, 2004.
  3. Obayashi K, Ando Y, Miida T, Nakamura T, Yamashita T, Ueda T, Haraoka K, Terazaki H, Okada M. Macroscopic assessment of skin venules in patients with familial amyloidotic polyneuropathy (FAP) using near-infrared spectrophotoscopy: As a marker of autonomic dysfunction. In: Amyloid and Amyloidosis (Gilles G, Kyle RA, Skinner M. Eds.), CRC Press, Boca Raton (U.S.A.), 334-336, 2004.
  4. Hanyu O, Miida T, Obayashi K, Ikarashi T, Soda S, Kaneko S, Hirayama S, Suzuki K, Nakamura Y, Yamatani K, Aizawa Y. Lipoprotein Lipase (LPL) mass in pre-heparin serum reflects insulin sensitivity. Atherosclerosis, Vol. 174, No. 2, 385-390, 2004.
  5. Miida T, Zhang B, Obayashi K, Seino U, Zhu Y, Ito T, Nakamura Y, Okada M, Saku K. T13M mutation of lecithin-cholesterol acyltransferase gene causes fish-eye disease. Clin Chim Acta, Vol. 343, No. 1-2, 201-208, 2004.
  6. Miida T, Obayashi K, Seino U, Zhu Y, Ito T, Kosuge K, Hirayama S, Hanyu O, Nakamura Y, Yamaguchi T, Tsuda T, Saito Y, Miyazaki O, Nakamura Y, Okada M. LCAT-dependent conversion rate is a determinant of plasma preβ1-HDL concentration in healthy Japanese. Clin Chim Acta, Vol. 350, No. 1-2, 107-114, 2004.
  7. Tabe Y, Konopleva M, Munsell MF, Marini FC, Zompetta C, McQueen T, Tsao T, Zhao S, Pierce S, Igari J, Estey EH, Andreeff M. PML-RARalpha is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival. Blood, Vol. 103, No. 5, 1815-1822, 2004.
  8. Tabe Y, Konopleva M, Igari J, Andreeff M. Spontaneous migration of acute promyelocytic leukemia cells beneath cultured bone marrow adipocytes with matched expression of the major histocompatibility complex. Rinsho Byori, Vol. 52, No. 6, 642-648, 2004.
  9. Maruyama S, Ikarashi T, Soda S, Toya M, Okamura K, Hirayama S, Suzuki K, Hanyu O, Sakurabayashi T, Nakagawa O, Aizawa Y. A rare case of Graves' disease during regular hemodialysis. Clin Exp Nephrol, 8, 71-74, 2004.
  10. Zhu Y, Bujo H, Yamazaki H, Ohwaki K, Jiang M, Hirayama S, Kanaki T, Shibasaki M, Takahashi K, Schneider WJ, Saito Y. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration. Circ Res, 94, 752-758, 2004.
  11. Tanaga K, Bujo H, Zhu Y, Kanaki T, Hirayama S, Takahashi K, Inoue M, Mikami K, Schneider WJ, Saito Y. LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors. Arterioscler Thromb Vasc Biol, 24, 1422-1428, 2004.
▲上へ
　2003年
  1. Miida T, Miyazaki O, Hanyu O, Nakamura Y, Hirayama S, Narita I, Gejyo F, Ei I, Tasaki K, Kohda Y, Ohta T, Yata S, Fukamachi I, Okada M. LCAT-dependent conversion of preβ1-HDL into α-migrating HDL is severely delayed in hemodialysis patients. J Am Soc Nephrol, Vol. 14, No. 3, 732-738, 2003.
  2. Miida T, Miyazaki O, Nakamura Y, Hirayama S, Hanyu O, Fukamachi I, Okada M. Analytical performance of a sandwich enzyme immunoassay for preβ1-HDL in stabilized plasma. J Lipid Res, Vol. 44, No. 3, 645-650, 2003.
  3. Maruyama S, Kato K, Kodama M, Okura Y, Hirono S, Fuse K, Hanawa H, Nakagawa O, Nakazawa M, Miida T, Yaoita E, Yamamoto T, Inoue I, Aizawa Y. FR167653 suppresses the progression of experimental autoimmune myocarditis. Mol Cell Biochem, Vol. 246, No. 1-2, 39-44, 2003.
  4. Matsubara T, Ishibashi T, Hori T, Ozaki K, Mezaki T, Tsuchida K, Nasuno A, Kubota K, Tanaka T, Miida T, Aizawa Y, Nishio M. Association between coronary endothelial dysfunction and local inflammation of atherosclerotic coronary arteries. Mol Cell Biochem, Vol. 249, No. 1-2, 67-73, 2003.
  5. Mezaki T, Matsubara T, Hori T, Higuchi K, Nakamura A, Nakagawa I, Imai S, Ozaki K, Tuchida K, Nasuno A, Tanaka T, Kubota K, Nakano M, Miida T, Aizawa Y. Plasma levels of soluble thrombomodulin, C-reactive protein and serum amyloid A protein in the atherosclerotic coronary circulation. Jpn Heart J, Vol. 44, No. 5, 601-612, 2003.
  6. Ogawa K, Takamori Y, Suzuki K, Nagasawa M, Takano S, Kasahara Y, Nakamura Y, Kondo S, Sugamura K, Nakamura M, Nagata K. Guranulysin in human serum as a maker of cell-mediated immunity. Eur j Immunol 33, 1925-1933, 2003.
  7. Hirayama S, Bajari TM, Nimpf J, Schneider WJ. Receptor-mediated chicken oocyte growth: differential expression of endophilin isoforms in developing follicles. Biol Reprod, 68, 1850-1860, 2003.
  8. Hummel S, Lynn EG, Osanger A, Hirayama S, Nimpf J, Schneider WJ. Molecular characterization of the first avian LDL receptor: role in sterol metabolism of ovarian follicular cells. J Lipid Res, 44, 1633-1642, 2003.
  9. Hanyu O, Yamatani K, Ikarashi T, Soda S, Maruyama S, Kamimura T, Kaneko S, Hirayama S, Suzuki K, Nakagawa O, Nawa H, Aizawa Y. Brain-derived neurotrophic factor modulates glucagon secretion from pancreatic alpha cells: its contribution to glucose metabolism. Diabetes Obes Metab, 5, 27-37, 2003.
▲上へ
　2002年
  1. Maruyama S, Kato K, Kodama M, Hirono S, Fuse K, Nakagawa O, Nakazawa M, Miida T, Watanabe K, Yamamoto T, Aizawa Y. Fenofibrate, a peroxisome proliferator-activated receptor a activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats. J Atheroscler Thromb, Vol. 9, No. 2, 87-92, 2002.
  2. Miida T, Nakamura Y, Mezaki T, Hanyu O, Maruyama S, Horikawa Y, Izawa S, Yamada Y, Matsui H, Okada M. LDL-cholesterol and HDL-cholesterol decrease during the day. Ann Clin Biochem, Vol. 39, No. 3, 241-249, 2002.
  3. Murai T, Yamada T, Miida T, Arai K, Endo N, Hanyu T. Fenofibrate inhibits reactive amyloidosis in mice. Arthritis Reumatism, Vol. 46, No. 6, 1683-1688, 2002.
  4. Tamayose K, Sato N, Ando J, Sugimoto K, Oshimi K. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: Case report and review of the literature. Am J Hematol, Vol. 71, No. 4, 331-335, 2002.
  5. Yoshioka Y, Ohwada A, Harada N, Satoh N, Sakuraba S, Dambara T, Fukuchi Y. Increased circulating CD16+CD14dim monocytes in a patient with pulmonary alveolar proteinosis. Respirol, Vol. 7, No. 3, 273-279, 2002.
  6. Zhu Y, Bujo H, Yamazaki H, Hirayama S, Kanaki T, Takahashi K, Shibasaki M, Schneider WJ, Saito Y. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro. Circulation, 105, 1830-1836, 2002.
▲上へ
　2001年
  1. Sakatsume M, Kadomura M, Sakata I, Imai N, Kondo D, Osawa Y, Shimada H, Ueno M, Miida T, Nishi S, Arakawa M, Gejyo F. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity. Kidney International, Vol. 59, No. 5, 1911-1918, 2001.
  2. Taira K, Bujo H, Hirayama S, Yamazaki H, Kanaki T, Takahashi K, Ishii I, Miida T, Schneider WJ, Saito Y. LR11, A Mosaic LDL receptor family member, mediates the uptake of apo E-rich lipoproteins in vitro. Arterioscler Thromb Vasc Biol, Vol. 21, No. 9, 1501-1506, 2001.
  3. Ogawa K, Tanaka K, Ishii A, Nakamura Y, Kondo S, Sugamura K, Takano S, Nakamura M, Nagata K. A novel serum protein that is selectively produced by cytotoxic lymphocytes. J Immunol, 166, 6404-12, 2001.
  4. Okumura-Noji K, Sasai K, Zhan R, Kawaguchi H, Maruyama H, Tada T, Takahashi H, Okazaki M, Miida T, Sakuma N, Kimura G, Ohta N, Yokoyama S. Cholesteryl ester transfer protein-deficiency causes slow egg embryonation of Shistosoma japonicum. Biochem Biophys Res Commun, Vol. 286, No. 2, 305-310, 2001.
  5. Tabe Y, Nakamura A, Igari J. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates. J Infect Chemother, Vol. 7, 142-147, 2001.
  6. Noguchi M, Sato N, Sugimori H, Mori K, Oshimi K, A minor e-selectin ligand, CD65, is critical for extravascular infiltration of acute myeloid leukemia cells. Leukemia Research, Vol. 25, No. 10, 847-853, 2001.
▲上へ